Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 17, 2023
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
Kevin Heal Maintained (CBOE) at Strong Buy with Increased Target to $161 on, Aug 17th, 2023
Kevin Heal of Argus Research, Maintained "Cboe Global Markets, Inc." (CBOE) at Strong Buy with Increased Target from $148 to $161 on, Aug 17th, 2023.
Kevin has made no other calls on CBOE in the last 4 months.
There are 5 other peers that have a rating on CBOE. Out of the 5 peers that are also analyzing CBOE, 2 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jeremy Campbell of "Barclays" Maintained at Hold with Increased Target to $155 on, Monday, August 7th, 2023
- Christopher Allen of "Citigroup" Reiterated at Hold and Held Target at $130 on, Tuesday, July 11th, 2023
These are the ratings of the 3 analyists that currently disagree with Kevin
- Andrew Bond of "Rosenblatt" Maintained at Strong Buy with Increased Target to $172 on, Monday, August 7th, 2023
- Brian Bedell of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $155 on, Monday, August 7th, 2023
- Owen Lau of "Oppenheimer" Maintained at Buy with Increased Target to $162 on, Monday, August 7th, 2023
